Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 15,770
-80 (-0.50%)
Jun 10, 2026, 3:30 PM KST
Onconic Therapeutics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 20,328 | 15,784 | -8,093 | 1,682 | -14,432 | -15,149 |
Depreciation & Amortization | 528.44 | 528.44 | 452.67 | 460.13 | 199.66 | 181.88 |
Other Amortization | - | - | - | - | 1.18 | 1.08 |
Loss (Gain) From Sale of Assets | - | - | - | 0.7 | - | - |
Stock-Based Compensation | 696.53 | 696.53 | 1,026 | 578.03 | 472.48 | 163.17 |
Other Operating Activities | -2,587 | -2,255 | 4,427 | -774.88 | -277.64 | 6,829 |
Change in Accounts Receivable | -3,647 | -3,647 | -7,222 | 104.5 | -99 | -5.5 |
Change in Accounts Payable | 1,961 | 1,961 | 708.67 | - | - | - |
Change in Income Taxes | - | - | 463.39 | - | - | - |
Change in Other Net Operating Assets | -3,691 | -1,673 | 396.57 | 2,089 | -825.75 | -879.32 |
Operating Cash Flow | 13,588 | 11,395 | -7,841 | 4,140 | -14,961 | -8,859 |
Capital Expenditures | -342.9 | -302.9 | -141.28 | -1,157 | -2,575 | -2.67 |
Sale of Property, Plant & Equipment | - | - | - | 38 | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | - | -5.88 |
Investment in Securities | -5,894 | -5,894 | - | - | - | - |
Other Investing Activities | - | - | 70.42 | 108.76 | 135.75 | - |
Investing Cash Flow | -6,237 | -6,197 | -70.85 | -1,011 | -2,439 | -8.55 |
Long-Term Debt Repaid | - | -194.35 | -179.92 | -153.85 | -142.06 | -142.06 |
Net Debt Issued (Repaid) | -194.45 | -194.35 | -179.92 | -153.85 | -142.06 | -142.06 |
Issuance of Common Stock | 2,124 | 1,279 | 19,762 | - | - | 7,498 |
Other Financing Activities | -1,611 | -1,611 | - | 114 | - | - |
Financing Cash Flow | 318.02 | -526.27 | 19,582 | -39.85 | 25,858 | 27,356 |
Foreign Exchange Rate Adjustments | -378.99 | -625.72 | 1,229 | -196.39 | - | - |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -108.76 | - | - |
Net Cash Flow | 7,291 | 4,046 | 12,899 | 2,784 | 8,458 | 18,488 |
Free Cash Flow | 13,245 | 11,092 | -7,982 | 2,983 | -17,536 | -8,861 |
Free Cash Flow Margin | 19.71% | 20.77% | -53.79% | 14.16% | -18458.96% | -14769.11% |
Free Cash Flow Per Share | - | 244.50 | -244.07 | 129.01 | -758.49 | -386.90 |
Cash Income Tax Paid | 960.82 | 959.21 | 912.06 | 2,170 | 2.18 | 2.71 |
Levered Free Cash Flow | 4,946 | 5,103 | -50,062 | 16,304 | 13,630 | - |
Unlevered Free Cash Flow | 4,952 | 5,111 | -49,646 | 17,413 | 14,304 | - |
Change in Working Capital | -5,377 | -3,359 | -5,653 | 2,193 | -924.75 | -884.82 |